Sign In
Buy WST
$316.31
+4.14 (+1.33%)
At Close: Jun 03, 2026
Artisan Global Opportunities Fund Q3 2025 Portfolio Update
08:10am, Thursday, 06'th Nov 2025
During the quarter, we initiated new positions in Spotify, L3Harris Technologies and Insmed. We also added to 3i Group, West Pharmaceutical and Amazon during the quarter. We ended our investment campa
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
06:00am, Monday, 27'th Oct 2025
EXTON, Pa. , Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of i
West to Participate in Upcoming Investor Conferences
06:00am, Friday, 24'th Oct 2025
EXTON, Pa. , Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will pre
Allspring Global Investments Holdings LLC Increases Stock Holdings in West Pharmaceutical Services, Inc. $WST
03:46am, Friday, 24'th Oct 2025
Allspring Global Investments Holdings LLC boosted its position in West Pharmaceutical Services, Inc. (NYSE: WST) by 13.2% during the undefined quarter, according to its most recent Form 13F filing wit
West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings Call Transcript
03:07pm, Thursday, 23'rd Oct 2025
West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants John Sweeney - Head of Investor Relations Eric Green - Non-Independent Chair of t
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
01:51pm, Thursday, 23'rd Oct 2025
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand
12:16pm, Thursday, 23'rd Oct 2025
West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company's third-quarter 2025 earnings surpassed analyst estimate
West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates
08:11am, Thursday, 23'rd Oct 2025
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.85 per share a year ago
West Pharma boosts annual profit forecast on strong demand for its drug components
06:52am, Thursday, 23'rd Oct 2025
Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after posting better-than-expected results for the third quarter, banking on strong demand for its components
West Reports Third-Quarter 2025 Results
06:00am, Thursday, 23'rd Oct 2025
- Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components - - Strengthened executive leadership team, including r
Head-To-Head Survey: Becton, Dickinson and Company (NYSE:BDX) vs. West Pharmaceutical Services (NYSE:WST)
01:58am, Thursday, 23'rd Oct 2025
Becton, Dickinson and Company (NYSE: BDX - Get Free Report) and West Pharmaceutical Services (NYSE: WST - Get Free Report) are both large-cap medical companies, but which is the superior stock? We wil
West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum
05:57am, Tuesday, 21'st Oct 2025
West Pharmaceutical Services earns a Buy rating with a $320 price target, reflecting ~18% upside with strong long-term growth prospects. WST's high-value product mix is expanding, driving margin growt
WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?
10:10am, Friday, 17'th Oct 2025
West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
09:06am, Wednesday, 15'th Oct 2025
WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.
West to Host Third-Quarter 2025 Conference Call
06:00am, Thursday, 09'th Oct 2025
EXTON, Pa. , Oct. 9, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will rele
